Adverse events in trial dent hopes for Roche hemophilia drug

LONDON (Reuters) - Four patients have suffered serious adverse events in a clinical trial of an experimental hemophilia medicine from Roche, the Swiss group said on Wednesday, clouding prospects for its potential blockbuster product.